It will help but obviously that's not a lot of shares in the scheme of things. Plus I can't see them paying more than they have to.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
TLS Telstra to boost phone plan prices despite inflation – and despite claiming they wouldn't 2 months ago